期刊
TRENDS IN BIOTECHNOLOGY
卷 30, 期 6, 页码 350-359出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tibtech.2012.03.003
关键词
-
资金
- Portuguese Foundation for Science and Technology [PTDC/BIO/72755/2006]
- European Commission [NMP4-CT-2004-500039, LSHB-CT-2006-018933, 223011]
- Fundação para a Ciência e a Tecnologia [PTDC/BIO/72755/2006] Funding Source: FCT
Human pluripotent stem cells (hPSCs), including embryonic and induced pluripotent stem cells, constitute an extremely attractive tool for cell therapy. However, flexible platforms for the large-scale production and storage of hPSCs in tightly controlled conditions are necessary to deliver high-quality cells in relevant quantities to satisfy clinical demands. Here we discuss the main principles for the bioprocessing of hPSCs, highlighting the impact of environmental factors, novel 3D culturing approaches and integrated bioreactor strategies for controlling hPSC culture outcome. Knowledge on hPSC bioprocessing accumulated during recent years provides important insights for the establishment of more robust production platforms and should potentiate the implementation of novel hPSC-based therapies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据